Cargando…

Alterations of Lipid Metabolism in Cancer: Implications in Prognosis and Treatment

Cancer remains the second leading cause of mortality worldwide. In the course of this multistage and multifactorial disease, a set of alterations takes place, with genetic and environmental factors modulating tumorigenesis and disease progression. Metabolic alterations of tumors are well-recognized...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernández, Lara P., Gómez de Cedrón, Marta, Ramírez de Molina, Ana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7655926/
https://www.ncbi.nlm.nih.gov/pubmed/33194695
http://dx.doi.org/10.3389/fonc.2020.577420
_version_ 1783608269031342080
author Fernández, Lara P.
Gómez de Cedrón, Marta
Ramírez de Molina, Ana
author_facet Fernández, Lara P.
Gómez de Cedrón, Marta
Ramírez de Molina, Ana
author_sort Fernández, Lara P.
collection PubMed
description Cancer remains the second leading cause of mortality worldwide. In the course of this multistage and multifactorial disease, a set of alterations takes place, with genetic and environmental factors modulating tumorigenesis and disease progression. Metabolic alterations of tumors are well-recognized and are considered as one of the hallmarks of cancer. Cancer cells adapt their metabolic competences in order to efficiently supply their novel demands of energy to sustain cell proliferation and metastasis. At present, there is a growing interest in understanding the metabolic switch that occurs during tumorigenesis. Together with the Warburg effect and the increased glutaminolysis, lipid metabolism has emerged as essential for tumor development and progression. Indeed, several investigations have demonstrated the consequences of lipid metabolism alterations in cell migration, invasion, and angiogenesis, three basic steps occurring during metastasis. In addition, obesity and associated metabolic alterations have been shown to augment the risk of cancer and to worsen its prognosis. Consequently, an extensive collection of tumorigenic steps has been shown to be modulated by lipid metabolism, not only affecting the growth of primary tumors, but also mediating progression and metastasis. Besides, key enzymes involved in lipid-metabolic pathways have been associated with cancer survival and have been proposed as prognosis biomarkers of cancer. In this review, we will analyze the impact of obesity and related tumor microenviroment alterations as modifiable risk factors in cancer, focusing on the lipid alterations co-occurring during tumorigenesis. The value of precision technologies and its application to target lipid metabolism in cancer will also be discussed. The degree to which lipid alterations, together with current therapies and intake of specific dietary components, affect risk of cancer is now under investigation, and innovative therapeutic or preventive applications must be explored.
format Online
Article
Text
id pubmed-7655926
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-76559262020-11-13 Alterations of Lipid Metabolism in Cancer: Implications in Prognosis and Treatment Fernández, Lara P. Gómez de Cedrón, Marta Ramírez de Molina, Ana Front Oncol Oncology Cancer remains the second leading cause of mortality worldwide. In the course of this multistage and multifactorial disease, a set of alterations takes place, with genetic and environmental factors modulating tumorigenesis and disease progression. Metabolic alterations of tumors are well-recognized and are considered as one of the hallmarks of cancer. Cancer cells adapt their metabolic competences in order to efficiently supply their novel demands of energy to sustain cell proliferation and metastasis. At present, there is a growing interest in understanding the metabolic switch that occurs during tumorigenesis. Together with the Warburg effect and the increased glutaminolysis, lipid metabolism has emerged as essential for tumor development and progression. Indeed, several investigations have demonstrated the consequences of lipid metabolism alterations in cell migration, invasion, and angiogenesis, three basic steps occurring during metastasis. In addition, obesity and associated metabolic alterations have been shown to augment the risk of cancer and to worsen its prognosis. Consequently, an extensive collection of tumorigenic steps has been shown to be modulated by lipid metabolism, not only affecting the growth of primary tumors, but also mediating progression and metastasis. Besides, key enzymes involved in lipid-metabolic pathways have been associated with cancer survival and have been proposed as prognosis biomarkers of cancer. In this review, we will analyze the impact of obesity and related tumor microenviroment alterations as modifiable risk factors in cancer, focusing on the lipid alterations co-occurring during tumorigenesis. The value of precision technologies and its application to target lipid metabolism in cancer will also be discussed. The degree to which lipid alterations, together with current therapies and intake of specific dietary components, affect risk of cancer is now under investigation, and innovative therapeutic or preventive applications must be explored. Frontiers Media S.A. 2020-10-28 /pmc/articles/PMC7655926/ /pubmed/33194695 http://dx.doi.org/10.3389/fonc.2020.577420 Text en Copyright © 2020 Fernández, Gómez de Cedrón and Ramírez de Molina. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Fernández, Lara P.
Gómez de Cedrón, Marta
Ramírez de Molina, Ana
Alterations of Lipid Metabolism in Cancer: Implications in Prognosis and Treatment
title Alterations of Lipid Metabolism in Cancer: Implications in Prognosis and Treatment
title_full Alterations of Lipid Metabolism in Cancer: Implications in Prognosis and Treatment
title_fullStr Alterations of Lipid Metabolism in Cancer: Implications in Prognosis and Treatment
title_full_unstemmed Alterations of Lipid Metabolism in Cancer: Implications in Prognosis and Treatment
title_short Alterations of Lipid Metabolism in Cancer: Implications in Prognosis and Treatment
title_sort alterations of lipid metabolism in cancer: implications in prognosis and treatment
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7655926/
https://www.ncbi.nlm.nih.gov/pubmed/33194695
http://dx.doi.org/10.3389/fonc.2020.577420
work_keys_str_mv AT fernandezlarap alterationsoflipidmetabolismincancerimplicationsinprognosisandtreatment
AT gomezdecedronmarta alterationsoflipidmetabolismincancerimplicationsinprognosisandtreatment
AT ramirezdemolinaana alterationsoflipidmetabolismincancerimplicationsinprognosisandtreatment